PathogenDX
Home to DNA scientists credited with over 50 patents, PathogenDx invented microarray technology enabling the testing of over 100 samples a day for pathogen testing. Now, regulated microbials can be tested in one simple test—driving cost savings of 20% over competitive solutions.
Content by PathogenDX
|2 min read
PathogenDx Receives Federal Grant From the NIH as Part of the RADx Program
The capital will be used to scale up testing capacity of PathogenDx’s Microarray Assay for COVID-19 testing nationallyPage 1 of 1
